Genomma Lab InternacionalB de CV (MEX:LABB) Forward Dividend Yield %: 5.32% (As of Jun. 26, 2026)


MEX:LABB Genomma Lab Internacional SAB de CV MEX:LABB
66 GF Score
Price MXN15.04
GF Value MXN17.64
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Genomma Lab InternacionalB de CV Forward Dividend Yield %?

Genomma Lab InternacionalB de CV MEX:LABB +2.59% 66 Forward Dividend Yield % is 5.32% as of Jun. 26, 2026. GuruFocus rates MEX:LABB with a GF Score™ of 66/100 and a GF Value™ of MXN17.64 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 504 Drug Manufacturers companies, Genomma Lab InternacionalB de CV ranks better than 88.69% on this metric.

As of today (2026-06-26), the Forward Annual Dividend Yield of Genomma Lab InternacionalB de CV is 5.32%.

As of today (2026-06-26), the Trailing Annual Dividend Yield of Genomma Lab InternacionalB de CV is 5.32%.

MEX:LABB's Forward Dividend Yield % is ranked better than
88.69% of 504 companies
in the Drug Manufacturers industry
Industry Median: 2.08 vs MEX:LABB: 5.32

Genomma Lab InternacionalB de CV's Dividends per Share for the three months ended in Mar. 2026 was MXN0.20.

During the past 3 years, the average Dividends Per Share Growth Rate was -11.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Genomma Lab InternacionalB de CV was -11.30% per year. The lowest was -11.40% per year. And the median was -11.35% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Genomma Lab InternacionalB de CV  (MEX:LABB) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Genomma Lab InternacionalB de CV Forward Dividend Yield % Related Terms

MEX:LABB vs ZTS, UTHR, VTRS: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomma Lab InternacionalB de CV Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Forward Dividend Yield % falls into.


MEX:LABB
66GF Score
Genomma Lab Internacional SAB de CV MEX:LABB
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomma Lab InternacionalB de CV Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Genomma Lab InternacionalB de CV Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
MXN 0.2000002026-06-262026-06-262026-06-29Cash DividendquarterlyMXN:MXN 1.000000
MXN 0.2000002026-03-302026-03-302026-03-31Cash DividendquarterlyMXN:MXN 1.000000
MXN 0.2000002025-12-232025-12-232025-12-23Cash DividendquarterlyMXN:MXN 1.000000
MXN 0.2000002025-09-182025-09-182025-09-19Cash DividendquarterlyMXN:MXN 1.000000
MXN 0.2000002025-06-302025-06-302025-07-01Cash DividendquarterlyMXN:MXN 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Genomma Lab InternacionalB de CV's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.8/15.04
=5.32 %

Current Share Price is MXN15.04.
Genomma Lab InternacionalB de CV's Dividends per Share for the forward twelve months is calculated as MXN0.2 * 4 = MXN0.8.

Genomma Lab InternacionalB de CV's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=1/15.04
=6.65 %

Current Share Price is MXN15.04.
Genomma Lab InternacionalB de CV's Dividends per Share for the trailing twelve months (TTM) ended in Today is MXN1.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 5.32% mean?
Genomma Lab InternacionalB de CV (MEX:LABB) has a Forward Dividend Yield % of 5.32% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Genomma Lab InternacionalB de CV and its competitors. According to the industry distribution chart, Genomma Lab InternacionalB de CV ranks #57 out of 504 companies in the Drug Manufacturers industry, placing it in the top 11.3%.
Is Genomma Lab InternacionalB de CV's Forward Dividend Yield % too high?
Genomma Lab InternacionalB de CV's current Forward Dividend Yield % is 5.32%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.08. Genomma Lab InternacionalB de CV's value of 5.32% is 155.8% above this industry median. Based on the distribution chart, Genomma Lab InternacionalB de CV ranks #57 out of 504 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Genomma Lab InternacionalB de CV has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomma Lab InternacionalB de CV's Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Genomma Lab InternacionalB de CV ranks #57 out of 504 companies for Forward Dividend Yield %. This places Genomma Lab InternacionalB de CV in the top 11% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.08. Genomma Lab InternacionalB de CV's value of 5.32% is 155.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.08, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genomma Lab InternacionalB de CV's current Forward Dividend Yield % of 5.32% is 155.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Genomma Lab InternacionalB de CV and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genomma Lab InternacionalB de CV's current Forward Dividend Yield % is 5.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomma Lab InternacionalB de CV stock overvalued right now?
Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV (MEX:LABB) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN17.64, compared to a current price of MXN15.04 — trading 14.7% below its estimated fair value. The current Forward Dividend Yield % is 5.32% and 155.8% above the Drug Manufacturers industry median of 2.08. Genomma Lab InternacionalB de CV's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Genomma Lab InternacionalB de CV (MEX:LABB), the current Forward Dividend Yield % is 5.32% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomma Lab InternacionalB de CV (MEX:LABB) Overvalued in 2026?

Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV stock appears to be undervalued. The current stock price of MXN15.04 is trading 14.7% below its estimated GF Value™ of MXN17.64. GuruFocus considers Genomma Lab InternacionalB de CV to be Modestly Undervalued.

Key valuation signals for MEX:LABB:

  • Forward Dividend Yield %: 5.32%
  • GF Value™: MXN17.64 vs. price of MXN15.04 (14.7% below fair value)
  • GF Score™: 66/100 with 4 warning signs
  • Industry Position: 155.8% above the Drug Manufacturers median (#57 of 504)

No single metric tells the full story. See the MEX:LABB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomma Lab InternacionalB de CV Business Description

Other Exchanges GNMLF:USAGEKA:Germany
Address Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
66GF Score

Get the complete analysis for MEX:LABB

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN15.04
Price
MXN17.64
GF Value